Abstract:Background: Glioma represents the predominant subtype of brain tumor, characterized by an unfavorable prognosis. Current evidence indicates the involvement of microRNAs (miRNAs) in the initiation and progression of glioma malignancies. While miR-760 has been recognized in the context of tumorigenesis, its precise role in gliomas remains insufficiently explored. Methods: In this investigation, we harnessed the GSE25631 database to scrutinize the aberrant expression profiles of microRNAs, whereby the diminished expression of miR-760 in glioblastoma was validated. Our aim was to delineate the expression patterns of microRNA-760 (miR-760) and probe its prognostic significance within the realm of glioma. Employing quantitative real-time polymerase chain reaction, we ascertained the relative expression levels of miR-760 and MMP2 in glioma cell lines. The impact of miR-760 on cell proliferation, migration, and invasion was assessed through Cell Counting Kit-8 (CCK-8), 5-ethynyl-2'-deoxyuridine (EdU), and Transwell assays. Bioinformatics analysis corroborated the downstream target gene of miR-760. Furthermore, a luciferase reporter experiment was conducted to pinpoint MMP2 as the direct target gene of miR-760. The assessment of MMP2 protein levels was accomplished through Western blotting and immunofluorescence techniques. Result: Our data unequivocally revealed a substantial reduction in miR-760 expression within glioma tissues and cell lines. Heightened miR-760 levels exerted a restraining influence on the proliferation, migration, and invasion capabilities of glioma cell lines. The outcomes of our bioinformatics analysis unveiled the ability of miR-760 to engage with and curtail MMP2 expression. Collectively, these findings posit that miR-760 exerts a restraining influence on glioma growth by orchestrating the upregulation of miR-760 along the miR-760/MMP2 axis. Conclusion: The delineation of the miR-760/MMP2 axis promises to broaden our comprehension of the intricate molecular mechanisms underpinning glioma proliferation and may unveil prospective therapeutic avenues for the management of glioma.

A Central Role for MeCP2 in the Epigenetic Repression of Mir-200C During Epithelial-to-mesenchymal Transition of Glioma.

Transcriptional Repression of Mir-200 Family Members by Nanog in Colon Cancer Cells Induces Epithelial Mesenchymal Transition (Emt)

Methyl-CpG-binding Protein 2 Drives the Furin/TGF-β1/Smad Axis to Promote Epithelial–mesenchymal Transition in Pancreatic Cancer Cells

The Dual Role of Glioma Exosomal Micrornas: Glioma Eliminates Tumor Suppressor Mir-1298-5p Via Exosomes to Promote Immunosuppressive Effects of MDSCs

Mecp2 Inhibits Proliferation And Migration Of Breast Cancer Via Suppression Of Epithelial-Mesenchymal Transition

MeCP2, a Target of Mir-638, Facilitates Gastric Cancer Cell Proliferation Through Activation of the MEK1/2–ERK1/2 Signaling Pathway by Upregulating GIT1

MeCP2 Promotes Gastric Cancer Progression Through Regulating FOXF1/Wnt5a/β-Catenin and MYOD1/Caspase-3 Signaling Pathways

MeCP2 Promotes Gastric Cancer Progression Through Regulating FOXF1/Wnt5a/β-Catenin and MYOD1/Caspase-3 Signaling Pathways.

MECP2 Promotes the Growth of Gastric Cancer Cells by Suppressing Mir-338-mediated Antiproliferative Effect.

Role of Mir-132/Methyl-cpg-binding Protein 2 in the Regulation of Neural Stem Cell Differentiation

MIR517C Inhibits Autophagy and the Epithelial-to-mesenchymal (-Like) Transition Phenotype in Human Glioblastoma Through KPNA2-dependent Disruption of TP53 Nuclear Translocation.

GTF2E2 Downregulated by Mir-340-5p Inhibits the Malignant Progression of Glioblastoma

DNMT1 and EZH2 Mediated Methylation Silences the Microrna-200B/a/429 Gene and Promotes Tumor Progression.

Epigenetically Deregulated Mir-200C is Involved in a Negative Feedback Loop with DNMT3a in Gastric Cancer Cells.

WITHDRAWN: MiR-143 Suppresses the Epithelial-Mesenchymal Transition of Spinal Glioblastoma Through Down-Regulation of ERK5

MiR-760 Exerts a Critical Regulatory Role in Glioma Proliferation, Migration, and Invasion by Modulating MMP2 Expression

Cooperation of p300 and PCAF in the control of microRNA 200c/141 transcription and epithelial characteristics

EZH2-Mediated Microrna-139-5p Regulates Epithelial-Mesenchymal Transition and Lymph Node Metastasis of Pancreatic Cancer.

MiR-200c Inhibits the Tumor Progression of Glioma Via Targeting Moesin.

Downregulation of Mir‑205 is Associated with Glioblastoma Cell Migration, Invasion, and the Epithelial-Mesenchymal Transition, by Targeting ZEB1 Via the Akt/mTOR Signaling Pathway.

C-Met and CREB1 Are Involved in Mir-433-mediated Inhibition of the Epithelial–mesenchymal Transition in Bladder Cancer by Regulating Akt/GSK-3β/Snail Signaling